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Wssociation of Gene Polymorphisms
ith Coronary Artery Disease in
ow- or High-Risk Subjects
efined by Conventional Risk Factors
e read with interest the careful study by Hirashiki et al. (1), who,
pon examining 37 single nucleotide polymorphisms (SNPs) in 31
andidate genes, reported a significant association of coronary
rtery disease (CAD) with SNPs in the apolipoprotein E,
onnexin-37, stromelysin-1, and endothelial nitric oxide synthase
eNOS) genes. A polymorphism in the promoter (T786C) of the
atter gene was recently shown to bear functional consequences (2)
ecause the C allele creates a binding site for a replication protein
-1 that acts as a repressor of gene transcription (3). Accordingly,
ssential hypertensive patients carrying this allele exhibited a
lunted forearm vasodilation in response to acetylcholine (4). This
llele was shown to be significantly associated with coronary
asospasm and myocardial infarction (MI) in Japanese patients
2,5) and with multivessel CAD in consecutive Caucasian patients
ndergoing coronary angiography because of suspected CAD (6).
hus, the results of Hirashiki et al. (1) in the Japanese patient
opulation appear to be fully confirmatory of earlier reports (5),
ncluding our study of Caucasians (6), that were overlooked.
Based on the presence or absence of hypertension, hypercho-
esterolemia, and diabetes mellitus, subjects in the Hirashiki et al.
tudy (1) were divided into a high- and a low-risk group,
espectively, yet about 74% of their CAD patients had myocardial
nfarction (MI) and therefore cannot be considered at low risk.
ndeed, according to the Third Report of the National Cholesterol
ducation Program Expert Panel (Adult Treatment Panel III) (7),
hese individuals would represent high-risk patients (e.g., subjects
ith a 20% risk of cardiovascular events in the next 10 years).
oreover, as the investigators correctly pointed out, their popu-
ation comprises MI survivors. Thus, it remains unclear whether
he SNPs that showed a significant association with CAD in a
opulation that mainly comprised high-risk MI survivors repre-
ented markers of survival or of predisposition to CAD (e.g.,
rotective or nefarious genetic variants). In our consecutive pa-
ients, a minority (45.6%) had a history of MI (6). Accordingly,
lthough the mortality for MI might be higher in Western
ountries than in Japan, the majority of our patient population did
ot comprise MI survivors.
The significant association of the 786C allele with CAD was
onfirmed by Hirashiki et al. also in their high-risk men; however,
he researchers did not comment on this important finding. Of
nterest, we tested the hypothesis that the genetic predisposition to
enerate less nitric oxide (NO) was more detrimental under
onditions with blunted NO availability, such as age older than 60
ears, hypercholesterolemia, cigarette smoking, and low high
ensity lipoprotein (HDL) cholesterol. With such analysis we
ound not only a significant association of multivessel CAD with
he 786C allele but also, more importantly, a marked increase in
he relative risk of multivessel CAD from 1.7 (95% confidence
nterval: 1.11 to 2.55, p  0.014) in the overall population to 3.61
1.63 to 8.0, p  0.002) when at least four such conditions
oexisted. Thus, one of the SNPs that was found to be associated
ith CAD by Hirashiki et al. (1) does not seem to increase the risk of CAD independently of other risk factors. Instead, it appears to
eeply interact with environmental factors that blunt NO availability.
It must be kept in mind that association studies are peculiarly prone
o false positive results, particularly when controls are not randomly
elected, as in the study by Hirashiki et al. (1). Based on dividing the
atients into low- and high-risk groups, the investigators pinpointed
NPs that were significantly associated with CAD in low- and
igh-risk groups of men and women. As the investigators correctly
cknowledged, the large number of comparisons that were made
pened up the possibility of chance findings; furthermore, no infor-
ation on power of the subgroup analyses was furnished. Nonethe-
ess, the independent replication by Hirashiki et al. in a genetically
nrelated population of our report of an association of the 786C allele
ith multivessel CAD lends strong support to our conclusion that this
NP is an important genetic factor predisposing to the development
f multivessel CAD.
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